Target expression details
Target's General Information | |||||
---|---|---|---|---|---|
Target ID | T81100 | ||||
Target Name | SLC5A2 messenger RNA (SLC5A2 mRNA) | ||||
Synonyms | Solute carrier family 5 member 2 (mRNA); Na(+)/glucose cotransporter 2 (mRNA); Low affinity sodium-glucose cotransporter (mRNA) | ||||
Target Type | Successful | ||||
Gene Name | SLC5A2 | ||||
Biochemical Class | mRNA target | ||||
UniProt ID | SC5A2_HUMAN | ||||
Target's Expression Profile in Disease Related Tissue between Patients and Normal People | |||||
Disease | Type 2 diabetes | ||||
Example drug | ISIS-SGLT2 | Phase 1 | [1], [2], [3] | ||
Tissue | Liver tissue | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: -0.09 Z-score: -0.37 P-value: 3.26E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target's Expression Profile across Various Tissues of Healthy Individual | |||||
References | |||||
REF 1 | Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011). | ||||
REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
REF 3 | NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.